BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clark G, Strachan JA, Carey FA, Godfrey T, Irvine A, McPherson A, Brand J, Anderson AS, Fraser CG, Steele RJ. Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme. Gut 2021;70:106-13. [PMID: 32234803 DOI: 10.1136/gutjnl-2019-320297] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Benton SC, Piggott C, Blyuss O, Li SJ, Mathews C, Carroll M, Duffy S. Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening programme in England. J Med Screen 2021;:9691413211013376. [PMID: 33983066 DOI: 10.1177/09691413211013376] [Reference Citation Analysis]
2 Bissig S, Syrogiannouli L, Schneider R, Tal K, Selby K, Del Giovane C, Bulliard JL, Senn O, Ducros C, Schmid CPR, Marbet U, Auer R. Change in colorectal cancer (CRC) testing rates associated with the introduction of the first organized screening program in canton Uri, Switzerland: Evidence from insurance claims data analyses from 2010 to 2018. Prev Med Rep 2022;28:101851. [PMID: 35757577 DOI: 10.1016/j.pmedr.2022.101851] [Reference Citation Analysis]
3 Kanth P, Inadomi JM. Screening and prevention of colorectal cancer. BMJ 2021;374:n1855. [PMID: 34526356 DOI: 10.1136/bmj.n1855] [Reference Citation Analysis]
4 Young GP, Symonds EL, Nielsen HJ, Ferm L, Christensen IJ, Dekker E, van der Vlugt M, Mallant-Hent RC, Boulter N, Yu B, Chan M, Tevz G, LaPointe LC, Pedersen SK. Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer. Clin Epigenetics 2021;13:14. [PMID: 33478584 DOI: 10.1186/s13148-020-00999-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Denis B, Gendre I. Colonoscopy may be weak link in organised colorectal cancer screening programme with faecal immunochemical test. J Med Screen 2021;:9691413211061118. [PMID: 34866481 DOI: 10.1177/09691413211061118] [Reference Citation Analysis]
6 Din S, Gaya DR, Arnott IDR. COVID-19: Colorectal cancer endoscopic surveillance in IBD. Lancet Gastroenterol Hepatol 2021;6:526-7. [PMID: 34119037 DOI: 10.1016/S2468-1253(21)00168-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Clark GR, Digby J, Fraser CG, Strachan JA, Steele RJ. Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme. J Med Screen 2021;:9691413211056970. [PMID: 34806935 DOI: 10.1177/09691413211056970] [Reference Citation Analysis]
8 Benton SC, Piggott C, Zahoor Z, O'Driscoll S, Fraser CG, D'Souza N, Chen M, Georgiou Delisle T, Abulafi M. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems. Clin Chem Lab Med 2022. [PMID: 35637625 DOI: 10.1515/cclm-2021-1248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pelitari S, Gautham A, Mistry P, Mohan S, Brookes M, McKaig B, Shah A, Jewes S, Fieldhouse G, Veitch A, Murugananthan A. Impact on healthcare resources of switch from fecal occult blood test to fecal immunochemical test within the English Bowel Cancer Screening Program: a single-center study. Gastrointest Endosc 2021;94:598-606. [PMID: 33727015 DOI: 10.1016/j.gie.2021.03.014] [Reference Citation Analysis]
10 Calanzani N, Chang A, Van Melle M, Pannebakker MM, Funston G, Walter FM. Recognising Colorectal Cancer in Primary Care. Adv Ther 2021;38:2732-46. [PMID: 33864597 DOI: 10.1007/s12325-021-01726-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Stott KJ, Phillips B, Parry L, May S. Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer. Biosci Rep 2021:BSR20204113. [PMID: 34236075 DOI: 10.1042/BSR20204113] [Reference Citation Analysis]
12 Barnett KN, Clark GRC, Steele RJC, Fraser CG. Faecal Haemoglobin Estimated by Faecal Immunochemical Tests-An Indicator of Systemic Inflammation with Real Clinical Potential. Diagnostics (Basel) 2021;11:2093. [PMID: 34829442 DOI: 10.3390/diagnostics11112093] [Reference Citation Analysis]
13 Toyoshima O, Yamaji Y, Nishizawa T, Yoshida S, Yamada T, Kurokawa K, Obata M, Kondo R, Toba M, Koike K. Priority stratification for colonoscopy based on two-sample faecal immunochemical test screening: results from a cross-sectional study at an endoscopy clinic in Japan. BMJ Open 2021;11:e046055. [PMID: 34011594 DOI: 10.1136/bmjopen-2020-046055] [Reference Citation Analysis]
14 Ng OH, Lunevicius R, Arthur JD. Rising incidence of colorectal cancer in individuals younger than 50 years and increasing mortality from rectosigmoid cancer in England. Colorectal Dis 2021. [PMID: 34310037 DOI: 10.1111/codi.15819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zou J, Xiao Z, Wu Y, Yang J, Cui N. Noninvasive fecal testing for colorectal cancer. Clin Chim Acta 2021:S0009-8981(21)00374-0. [PMID: 34756863 DOI: 10.1016/j.cca.2021.10.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Eddama MMR, Gurung R, Fragkos K, Lorgelly P, Cohen R, Loizidou M, Clapp L. The role of microvesicles as biomarkers in the screening of colorectal neoplasm. Cancer Med 2022. [PMID: 35343093 DOI: 10.1002/cam4.4664] [Reference Citation Analysis]
17 Clark GRC, Strachan JA, McPherson A, Digby J, Mowat C, Steele RJC, Fraser CG. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies. Clin Chem Lab Med 2020;58:2073-80. [PMID: 32324157 DOI: 10.1515/cclm-2020-0268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]